Dynamk Capital
Dynamk Capital is a venture capital firm dedicated to funding the future of life sciences. The firm focuses on accelerating innovation in tools and services within the life sciences sector, supporting entrepreneurs and investors in advancing healthcare solutions.
Dynamk Capital
Portfolio
Received up to $21M through ARPA-H as part of the Cancer Moonshot initiative.
#Life Sciences
Building an ecosystem to ramp up AAV production and selected as a lead project as part of NIIMBL's $10M biomanufacturing projects.
#Biotechnology
#Biotechnology
Leverages their 3D neuromuscular junction model for Botox potency assay in collaboration with Genetox and DreamCIS.
#Biotechnology
Highlighted by Memorial Sloan Kettering Cancer Center in The Scientist.
#Biotechnology
Announced collaboration with Waisman Biomanufacturing for GMP manufacturing of cell & exosome therapies.
#Biotechnology